Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vivus
Vivus
Arena - Scripts, Ads, Sales Reps
Seeking Alpha
Fri, 03/28/14 - 01:01 pm
Arena Pharmaceuticals
drug ads
drug reps
Belviq
Qsymia
Vivus
Vivus: Shares Are Oversold, Pressure Is On To Secure A Commercial Partner And Drive Market Penetration
Seeking Alpha
Wed, 03/26/14 - 04:58 pm
Vivus
Qsymia
Orexigen
Contrave
Belviq
Arena Pharmaceuticals
Vivus Announces Review Article Summarizing Cardiovascular Benefit-Risk Profile of Qsymia
Yahoo/Benzinga
Tue, 03/25/14 - 08:04 am
Vivus
Qsymia
The 5 Most Hated Biotechs: Myriad, Sarepta, OncoMed, VIVUS, and MannKind
Motley Fool
Fri, 03/14/14 - 08:39 am
biotech
Sarepta Therapeutics
OncoMed
Vivus
MannKind
Myriad Genetics
Have Anti-Obesity Drug Companies Failed?
Seeking Alpha
Fri, 03/7/14 - 03:56 pm
obesity
Arena Pharmaceuticals
Vivus
Orexigen
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data
Yahoo/Zacks.com
Wed, 03/5/14 - 11:46 am
InterMune
Esbriet
Alexion
Soliris
Vivus
Qsymia
Regeneron
Eylea
It's Always Darkest Before The Dawn: Why Vivus Could Double In Three Months And Triple In Twelve
Seeking Alpha
Mon, 03/3/14 - 11:51 am
Vivus
Qsymia
Stendra
VIVUS' Q4 Loss Shrinks 70% as Licensing Revenue Soars
Motley Fool
Mon, 02/24/14 - 05:39 pm
Vivus
earnings
Cheaper Obesity Drugs Available (for Half of Some Americans)
Daily Finance
Mon, 02/24/14 - 05:25 pm
obesity
Arena Pharmaceuticals
Eisai
Vivus
Orexigen
Belviq
Qsymia
Contrave
Biotech Showdown: Arena Pharmaceuticals vs. VIVUS Inc.
Motley Fool
Fri, 02/21/14 - 10:44 am
obesity
Arena Pharmaceuticals
Vivus
Belviq
Qsymia
Novo Nordisk
Orexigen
Arena Investors Await Strong Sales Data
Seeking Alpha
Mon, 01/27/14 - 08:17 am
Arena Pharmaceuticals
Belviq
Eisai
Orexigen
Vivus
VIVUS and Auxilium Announce FDA Acceptance of Supplemental Filing Seeking an Update of Prescribing Information for STENDRA (Avanafil)
Yahoo
Tue, 01/21/14 - 08:10 am
erectile dysfunction
Vivus
Auxilium
Stendra
FDA
VIVUS collaborates with Aetna on Qsymia
Yahoo/Fly on the Wall
Tue, 01/14/14 - 08:19 am
Vivus
Aetna
Qsymia
New ED Drug: Analysis Of Vivus's Prospects
Seeking Alpha
Thu, 01/9/14 - 08:26 am
erectile dysfunction
Vivus
Stendra
Pfizer
Viagra
Cialis
Eli Lilly
Actavis
Auxillium
Bayer
Vivus Scores Insurance Win
Seeking Alpha
Thu, 01/2/14 - 12:38 pm
Vivus
Orexigen
obesity
insurance
Caremark
Arena Pharmaceuticals
Qsymia
A Not-So Fat 2013 for This Obesity-Drug Maker
Motley Fool
Thu, 12/26/13 - 01:47 pm
obesity
Vivus
Qsymia
Eisai
Belviq
Arena Pharmaceuticals
Sanofi signs on to sell Vivus ED drug in emerging markets
Fierce Pharma
Fri, 12/13/13 - 04:52 pm
Vivus
erectile dysfunction
Sanofi
Stendra
Qsymia
The Weight Loss Drug Company Investors Need to Watch Out For
Motley Fool
Fri, 12/13/13 - 08:32 am
beloranib
Zafgen
Vivus
Arena Pharmaceuticals
Keep an Eye on AstraZeneca, Avanir, Bristol-Myers Squibb and VIVUS Today
Motley Fool
Thu, 12/12/13 - 11:12 am
AstraZeneca
Avair
Bristol-Myers Squibb
Vivus
metreleptin
Nuedexta
Avanafil
Sanofi
Will These Drugmakers Profit From Patient Weight Loss?
Motley Fool
Wed, 12/4/13 - 03:47 pm
obesity
Victoza
Novo Nordisk
Contrave
Orexigen
Vivus
Qsymia
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »